Company: PIII
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001140361-25-016302
Chunk: 1

Company: P3 Health Partners Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 1
---
 |     | 32 |
| DIRECTOR COMPENSATION                                                                          |     | 34 |
| Non-Employee Director Compensation Table                                                       |     | 35 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                                 |     | 36 |
| Delinquent Section 16(a) Reports                                                               |     | 39 |
| CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS                                          |     | 40 |
| Policies and Procedures for Approval of Related Person Transactions                            |     | 40 |
| Relationships and Transactions with Directors, Executive Officers and Significant Stockholders |     | 40 |
| Transactions in connection with the Business Combinations                                      |     | 40 |
| STOCKHOLDERS’ PROPOSALS                                                                        |     | 48 |
| OTHER MATTERS                                                                                  |     | 49 |
| SOLICITATION OF PROXIES                                                                        |     | 49 |
| OUR ANNUAL REPORT ON FORM 10-K                                                                 |     | 50 |

ii

TABLE OF CONTENTS

P3 HEALTH PARTNERS INC. 2370 Corporate Circle, Suite 300 Henderson, Nevada 89074 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD WEDNESDAY, JUNE 4, 2025 The Annual Meeting of Stockholders (the “Annual Meeting”) of P3 Health Partners Inc., a Delaware corporation (the “Company”), will be held at 9:00 a.m. Pacific Time on Wednesday, June 4, 2025. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to attend the Annual Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/PIII2025and entering your 16-digit control number included on your proxy card or on the instructions that accompanied your proxy materials. The Annual Meeting will be held for the following purposes:

| • | To elect Sherif Abdou, M.D., Greg Kazarian and Greg Wasson as Class I Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified; |

| • | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers; |

| • | To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 1,428,129 shares of Class A common stock upon the exercise of outstanding